Justin Chiong

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 111 citations · Full text

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 76 citations · Full text

Vaccination, Covid-19 Pandemic, Vaccine Trial +8

Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro

Rohan Gurjar, Christina Y. Chan, Paul Curley et al. · Molecular Pharmaceutics · 2018 · 57 citations

Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK

Rajith K. R. Rajoli, Charles Flexner, Justin Chiong et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 51 citations · Full text

Engineering, Long-acting Antiretrovirals, Microfabrication +6

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

Thokozile R. Malaba, Irene Nakatudde, Kenneth Kintu et al. · The Lancet HIV · 2022 · 50 citations · Full text